Peer-influenced content. Sources you trust. No registration required. This is HCN.
Annals of the Rheumatic Diseases (ARD)
To limit or even avoid the negative impact of ERA and JPsA on patient development, QoL or disease-associated joint damage, rapid and sustained control of disease signs and symptoms is recommended.
Pediatrics April 9th 2026
Cleveland Clinic Journal of Medicine (CCJM)
The study highlights the potential of immune cell profiling in identifying PsA patients who are more challenging to treat, paving the way for personalized treatment strategies.
Rheumatology January 4th 2024
DIET & NUTRITION 
PATIENT EDUCATION 
OBESITY/WEIGHT MANAGEMENT 
EXERCISE/TRAINING 
LEGAL MATTERS 
GUIDELINES/RECOMMENDATIONS